(Q80202490)
Statements
ADDRESS (ADministration of DRotrecogin alfa [activated] in Early stage Severe Sepsis) long-term follow-up: one-year safety and efficacy evaluation (English)
Pierre-Francois Laterre
Edward Abraham
Jonathan M Janes
Benjamin L Trzaskoma
Nancy L Correll